Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: A pilot study

Journal of Feline Medicine and Surgery

Volumn 13, Issue 6, 2011, Pages 418-426

  Quimby, Jessica M ^a   Webb, Tracy L ^a   Gibbons, Debra S ^a   Dow, Steven W ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE;

ADIPOSE TISSUE; ANIMAL; ANIMAL DISEASE; ARTICLE; AUTOTRANSPLANTATION; BLOOD; BONE MARROW TRANSPLANTATION; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; CYTOLOGY; ENDOSCOPIC ECHOGRAPHY; EVALUATION; FEASIBILITY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; INJECTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; PILOT STUDY; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ADIPOSE TISSUE; ANIMALS; BONE MARROW TRANSPLANTATION; CAT DISEASES; CATS; CREATINE; FEASIBILITY STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; INJECTIONS; KIDNEY FAILURE, CHRONIC; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PILOT PROJECTS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79956112433     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2011.01.005     Document Type: Article

References (32)

1. Adin C.A., Gregory C.R., Kyles A.E., Cowgill L. Diagnostic predictors of complications and survival after renal transplantation in cats. Vet Surg 2001, 30:515-521.
2. Schmiedt C.W., Holzman G., Schwarz T., McAnulty J.F. Survival, complications, and analysis of risk factors after renal transplantation in cats. Vet Surg 2008, 37:683-695.
3. Roudebush P., Polzin D.J., Ross S.J., et al. Therapies for feline chronic kidney disease. What is the evidence?. J Feline Med Surg 2009, 11:195-210.
4. Plotnick A. Feline chronic renal failure: long-term medical management. Compend Contin Educ Vet 2007, 29:342-344. 46-50; quiz 51.
5. Choi S., Park M., Kim J., et al. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 2009, 18:521-529.
6. Kirpatovskii V.I., Kazachenko A.V., Plotnikov E.Y., et al. Functional aftereffects of intraparenchymatous injection of human fetal stem and progenitor cells to rats with chronic and acute renal failure. Bull Exp Biol Med 2006, 141:500-506.
7. Semedo P., Correa-Costa M., Antonio Cenedeze M., et al. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 2009, 27:3063-3073.
8. Cavaglieri R.C., Martini D., Sogayar M.C., Noronha I.L. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc 2009, 41:947-951.
9. Caldas H.C., Fernandes I.M., Gerbi F., et al. Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant Proc 2008, 40:853-855.
10. Ninichuk V., Gross O., Segerer S., et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006, 70:121-129.
11. Kunter U., Rong S., Boor P., et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 2007, 18:1754-1764.
12. Ezquer F., Ezquer M., Simon V., et al. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biol Blood Marrow Transplant 2009, 15:1354-1365.
13. Wong C.Y., Cheong S.K., Mok P.L., Leong C.F. Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model. Pathology 2008, 40:52-57.
14. Prodromidi E.I., Poulsom R., Jeffery R., et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006, 24:2448-2455.
15. Imasawa T., Utsunomiya Y. Stem cells in renal biology: bone marrow transplantation for the treatment of IgA nephropathy. Exp Nephrol 2002, 10:51-58.
16. Imasawa T., Nagasawa R., Utsunomiya Y., et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int 1999, 56:1809-1817.
17. Sugimoto H., Mundel T.M., Sund M., et al. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A 2006, 103:7321-7326.
18. Guillot P.V., Cook H.T., Pusey C.D., et al. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol 2008, 214:627-636.
19. Togel F., Yang Y., Zhang P., Hu Z., Westenfelder C. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol 2008, 295:F315-F321.
20. Togel F., Weiss K., Yang Y., et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007, 292:F1626-F1635.
21. Avery P.R., Lehman T.L., Hoover E.A., Dow S.W. Sustained generation of tissue dendritic cells from cats using organ stromal cell cultures. Vet Immunol Immunopathol 2007, 117:222-235.
22. Kolf C.M., Cho E., Tuan R.S. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007, 9:204.
23. Locke M., Windsor J., Dunbar P.R. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 2009, 79:235-244.
24. Vieria N.M., Brandalise V., Zucconi E., et al. Isolation, characterization and differentiation potential of canine adipose-derived stem cells. Cell Transplant Transplant 2010, 19:279-289.
25. Reger R.L., Tucker A.H., Wolfe M.R. Differentiation and characterization of human MSCs. Methods in molecular biology; mesenchymal stem cells: methods and protocols 2008, Humana Press, Totowa, NJ. D.J. Prockop, D.J. Phinney, B.A. Bunnell (Eds.).
26. Martin D.R., Cox N.R., Hathcock T.L., Niemeyer G.P., Baker H.J. Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp Hematol 2002, 30:879-886.
27. Kerl M.E., Cook C.R. Glomerular filtration rate and renal scintigraphy. Clin Tech Small Anim Pract 2005, 20:31-38.
28. Boyd L.M., Langston C., Thompson K., Zivin K., Imanishi M. Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med 2008, 22:1111-1117.
29. Stenderup K., Justesen K., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
30. Togel F., Cohen A., Zhang P., et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 2009, 18:475-485.
31. Wolf D., Reinhard A., Seckinger A., et al. Regenerative capacity of intravenous autologous, allogeneic and human mesenchymal stem cells in the infarcted pig myocardium-complicated by myocardial tumor formation. Scand Cardiovasc J 2009, 43:39-45.
32. McTaggart S.J., Atkinson K. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease. Nephrology (Carlton) 2007, 12:44-52.